• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三碘甲状腺原氨酸调节前列腺癌细胞系LNCaP的生长、分泌功能及雄激素受体浓度。

Triiodothyronine modulates growth, secretory function and androgen receptor concentration in the prostatic carcinoma cell line LNCaP.

作者信息

Esquenet M, Swinnen J V, Heyns W, Verhoeven G

机构信息

Department of Developmental Biology, Catholic University of Leuven, Belgium.

出版信息

Mol Cell Endocrinol. 1995 Mar;109(1):105-11. doi: 10.1016/0303-7207(95)03490-x.

DOI:10.1016/0303-7207(95)03490-x
PMID:7540569
Abstract

There is increasing evidence that the course of prostatic carcinoma is determined by a complex interplay between genetic events, paracrine interactions, and hormonal and dietary factors. These latter factors include several ligands of the nuclear receptor family such as androgens, vitamin D3 and retinoids. To test whether thyroid hormones also influence the growth and differentiated function of prostatic carcinoma cells, LNCaP cells were treated with or without triiodothyronine (T3) in the absence or in the presence of other regulatory factors. Exposure of LNCaP cells to T3 for 6 days in the absence of androgens caused a dose-dependent increase in [3H]-thymidine incorporation with a maximal stimulation of 2.5-fold at 10(-9) M T3. Secretion of prostate-specific antigen (PSA) was also stimulated 2-3-fold. The observed effects may well be mediated by a nuclear T3 receptor as evidenced by displaceable T3 binding studies. Combined treatment of LNCaP cells with androgens and T3 revealed intriguing interactions between these two pathways. Below and up to 10(-10) M of the synthetic androgen R1881, the concentration that evokes optimal proliferative responses, T3 stimulated [3H] thymidine incorporation. At higher concentrations of androgens, T3 displayed antiproliferative effects. No androgen-dependent effects on T3 receptor levels were observed. Conversely, T3 increased androgen receptor levels up to twofold. Androgen as well as T3 stimulation of proliferation was abolished by high concentrations of the retinoid 9-cis-retinoic acid. These data add T3 to the list of factors that influence growth and differentiation of prostatic tumor cells and contribute to our understanding of the intricate pathways that ultimately determine the course of prostatic carcinoma.

摘要

越来越多的证据表明,前列腺癌的病程由基因事件、旁分泌相互作用以及激素和饮食因素之间的复杂相互作用所决定。后一类因素包括核受体家族的几种配体,如雄激素、维生素D3和视黄酸。为了测试甲状腺激素是否也影响前列腺癌细胞的生长和分化功能,在有或没有其他调节因子的情况下,用或不用三碘甲状腺原氨酸(T3)处理LNCaP细胞。在没有雄激素的情况下,将LNCaP细胞暴露于T3 6天会导致[3H]-胸腺嘧啶核苷掺入量呈剂量依赖性增加,在10(-9) M T3时最大刺激为2.5倍。前列腺特异性抗原(PSA)的分泌也被刺激了2至3倍。可置换的T3结合研究证明,观察到的效应很可能由核T3受体介导。用雄激素和T3联合处理LNCaP细胞揭示了这两条途径之间有趣的相互作用。在合成雄激素R1881达到并低于10(-10) M(即引起最佳增殖反应的浓度)时,T3刺激[3H]胸腺嘧啶核苷掺入。在雄激素浓度较高时,T3表现出抗增殖作用。未观察到雄激素对T3受体水平的依赖性效应。相反,T3使雄激素受体水平增加了两倍。高浓度的类视黄醇9-顺式视黄酸消除了雄激素以及T3对增殖的刺激。这些数据将T3添加到影响前列腺肿瘤细胞生长和分化的因素列表中,并有助于我们理解最终决定前列腺癌病程的复杂途径。

相似文献

1
Triiodothyronine modulates growth, secretory function and androgen receptor concentration in the prostatic carcinoma cell line LNCaP.三碘甲状腺原氨酸调节前列腺癌细胞系LNCaP的生长、分泌功能及雄激素受体浓度。
Mol Cell Endocrinol. 1995 Mar;109(1):105-11. doi: 10.1016/0303-7207(95)03490-x.
2
Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1alpha,25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate.LNCaP细胞增殖与分化的调控:雄激素、1α,25-二羟基维生素D3、全反式维甲酸、9-顺式维甲酸及苯乙酸的作用与相互作用
Prostate. 1996 Mar;28(3):182-94. doi: 10.1002/(SICI)1097-0045(199603)28:3<182::AID-PROS5>3.0.CO;2-H.
3
LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids.来自低传代次数和高传代次数的LNCaP前列腺腺癌细胞不仅对雄激素,而且对视黄酸表现出不同的反应。
J Steroid Biochem Mol Biol. 1997 Aug;62(5-6):391-9. doi: 10.1016/s0960-0760(97)00054-x.
4
Effect of retinoic acid on the proliferation and secretory activity of androgen-responsive prostatic carcinoma cells.视黄酸对雄激素反应性前列腺癌细胞增殖和分泌活性的影响。
J Urol. 1993 May;149(5):1190-4. doi: 10.1016/s0022-5347(17)36345-0.
5
Interactive effects of triiodothyronine and androgens on prostate cell growth and gene expression.三碘甲状腺原氨酸与雄激素对前列腺细胞生长及基因表达的交互作用。
Endocrinology. 1999 Apr;140(4):1665-71. doi: 10.1210/endo.140.4.6666.
6
Androgens decrease and retinoids increase the expression of insulin-like growth factor-binding protein-3 in LNcaP prostatic adenocarcinoma cells.雄激素可降低而维甲酸可增加胰岛素样生长因子结合蛋白-3在LNcaP前列腺腺癌细胞中的表达。
Mol Cell Endocrinol. 1999 Sep 10;155(1-2):9-18. doi: 10.1016/s0303-7207(99)00122-7.
7
Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP.含雄激素受体的人前列腺肿瘤细胞系LNCaP对特定蛋白质的雄激素依赖性生长调节及释放
Prostate. 1986;9(3):247-59. doi: 10.1002/pros.2990090305.
8
Retinoids stimulate lipid synthesis and accumulation in LNCaP prostatic adenocarcinoma cells.维甲酸刺激LNCaP前列腺腺癌细胞中的脂质合成和积累。
Mol Cell Endocrinol. 1997 Dec 31;136(1):37-46. doi: 10.1016/s0303-7207(97)00210-4.
9
Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP.雄激素抑制人前列腺癌细胞系LNCaP的一个变体的增殖。
J Steroid Biochem Mol Biol. 1995 Oct;55(1):67-76. doi: 10.1016/0960-0760(95)00155-s.
10
1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.1α,25-二羟基维生素D3在LNCaP人前列腺癌细胞中的作用是雄激素依赖性的。
Endocrinology. 1997 Aug;138(8):3290-8. doi: 10.1210/endo.138.8.5328.

引用本文的文献

1
Process to radioactive iodine treatment for Graves' hyperthyroidism: condemned or absolved?格雷夫斯病甲亢的放射性碘治疗流程:应受谴责还是可免责?
J Endocrinol Invest. 2025 Aug 6. doi: 10.1007/s40618-025-02653-x.
2
Targeting Androgen, Thyroid Hormone, and Vitamin A and D Receptors to Treat Prostate Cancer.靶向雄激素、甲状腺激素和维生素 A、D 受体治疗前列腺癌。
Int J Mol Sci. 2024 Aug 26;25(17):9245. doi: 10.3390/ijms25179245.
3
Prostate gland as a target organ of thyroid hormones: advances and controversies.前列腺作为甲状腺激素的靶器官:进展与争议
Endocr Connect. 2022 Feb 14;11(2):e210581. doi: 10.1530/EC-21-0581.
4
Triiodothyronine Attenuates Prostate Cancer Progression Mediated by β-Adrenergic Stimulation.三碘甲状腺原氨酸减弱由β-肾上腺素能刺激介导的前列腺癌进展。
Mol Med. 2016 Sep;22:1-11. doi: 10.2119/molmed.2015.00047. Epub 2016 Feb 26.
5
Vitamin D, intermediary metabolism and prostate cancer tumor progression.维生素D、中间代谢与前列腺癌肿瘤进展
Front Physiol. 2014 May 15;5:183. doi: 10.3389/fphys.2014.00183. eCollection 2014.
6
Thyroid hormone receptors regulate adipogenesis and carcinogenesis via crosstalk signaling with peroxisome proliferator-activated receptors.甲状腺激素受体通过与过氧化物酶体增殖物激活受体的交叉对话信号调节脂肪生成和致癌作用。
J Mol Endocrinol. 2010 Mar;44(3):143-54. doi: 10.1677/JME-09-0107. Epub 2009 Sep 9.
7
Novel oncogenic actions of TRbeta mutants in tumorigenesis.TRβ突变体在肿瘤发生中的新型致癌作用。
IUBMB Life. 2009 May;61(5):528-36. doi: 10.1002/iub.180.
8
Cyclin D1 repressor domain mediates proliferation and survival in prostate cancer.细胞周期蛋白D1抑制域介导前列腺癌的增殖和存活。
Oncogene. 2009 Feb 19;28(7):1016-27. doi: 10.1038/onc.2008.446. Epub 2008 Dec 15.
9
Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells.白细胞介素1β介导单核细胞对LNCaP人前列腺癌细胞的调节作用。
Br J Cancer. 1998 Oct;78(8):1004-11. doi: 10.1038/bjc.1998.619.